Gene · 8405
Papers2,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interpretable deep learning framework for mapping E3-substrate binding interfaces. | Nat Commun | 2026 | 42161910 | PubTator, text mining | PubMed |
| Nabais Sá-de Vries Syndrome Type 1 in a Mexican Girl: A Case Report. | Cureus | 2026 | 42147571 | PubTator, text mining | PubMed |
| Genomics of MTAP Loss in >500,000 Solid Tumor Specimens Profiled Using Comprehensive Genomic Profiling Platforms. | JCO Precis Oncol | 2026 | 42133901 | PubTator, text mining | PubMed |
| IDH1 Mutations Are Associated with Favorable Outcomes in Prostate Cancer. | Eur Urol | 2026 | 42128753 | PubTator, text mining | PubMed |
| SPOP-mediated K27-linked non-degradative ubiquitination of KCNN3 suppressing HCC progression via the CTCF-SATB1 axis. | Cell Death Dis | 2026 | 42106340 | PubTator, text mining | PubMed |
| Functional dissection of SPOP at the amino acid level reveals a comprehensive functional landscape of variants during tumorigenesis. | Proc Natl Acad Sci U S A | 2026 | 42090249 | PubTator, text mining | PubMed |
| Gossypol Inhibits GLI3-dependent SHH Signaling to Selectively Target SPOP-deficient Breast Cancer Cells. | Anticancer Res | 2026 | 42049345 | PubTator, text mining | PubMed |
| Liquid-based genomic profiling in high-risk localized prostate cancer. | Front Urol | 2026 | 42038957 | PubTator, text mining | PubMed |
| Prognostic biomarkers and regulatory mechanisms associated with lysine β-hydroxybutyrylation modification in prostate cancer. | Front Mol Biosci | 2026 | 42037647 | PubTator, text mining | PubMed |
| B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer. | Clin Cancer Res | 2026 | 42012455 | PubTator, text mining | PubMed |
| [Research Progress on Glycolytic Reprogramming and Lactylation Crosstalk in Tumors]. | Zhongguo Fei Ai Za Zhi | 2026 | 41916915 | PubTator, text mining | PubMed |
| Real-world precision medicine data in metastatic prostate cancer - a retrospective cohort study. | Front Oncol | 2026 | 41878526 | PubTator, text mining | PubMed |
| Reduced YTHDF2 inhibits PD-L1 expression by stabilizing m6A-containing SPOP mRNA in colorectal cancer. | Cell Death Dis | 2026 | 41872151 | PubTator, text mining | PubMed |
| Evaluation of a gene expression panel for prognostic stratification in high-risk prostate cancer. | Cancer Treat Res Commun | 2026 | 41865695 | PubTator, text mining | PubMed |
| SPOP Mutations in Veterans With Prostate Cancer and Outcomes With Doublet and Triplet Therapy in De Novo Metastatic Hormone Sensitive Prostate Cancer. | Prostate | 2026 | 41855405 | PubTator, text mining | PubMed |
| Next Generation DNA Damage Response Inhibitors: Harnessing Nanocarriers and Tumor Microenvironment for Precision Cancer Therapy. | Oncol Res | 2026 | 41799521 | PubTator, text mining | PubMed |
| Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate Cancer. | JCO Precis Oncol | 2026 | 41785440 | PubTator, text mining | PubMed |
| Strategies to target PD-1/PD-L1 in the tumor microenvironment. | Cell Oncol (Dordr) | 2026 | 41784760 | PubTator, text mining | PubMed |
| Lactylation in urological malignancies: emerging mechanisms and therapeutic direction. | Front Cell Dev Biol | 2026 | 41768991 | PubTator, text mining | PubMed |
| Exploring treatment models for oligometastatic castration-sensitive prostate cancer: evolution of therapeutic strategies. | Front Oncol | 2026 | 41768233 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8405/papers?page=2